Objective
Endometrial cancer is the most common gynecologic malignancy in the United States and typically is diagnosed at an early stage (I or II), resulting in a 95% 5-year survival rate. The majority of women are cured with surgery alone. Women with endometrial cancer have high rates of stress urinary incontinence (SUI) that often go undiagnosed. The purpose of this pilot study was to determine whether women with early-stage endometrial cancer could be screened for SUI at their initial gynecologic oncology visit and referred to a urogynecologist for concurrent treatment of their endometrial cancer and SUI.
Study Design
This was a prospective pilot study approved by an intuitional review board and performed at a large academic center in the Northeast. Women with a new diagnosis of clinical stage I or II endometrial cancer who screened positive for SUI and planned surgical treatment for their endometrial cancer were eligible. Women were screened for SUI with a single question: “Do you ever leak urine when you cough, sneeze, jump, or laugh?” All participants were offered referral to a urogynecologist for evaluation of their SUI, and evaluation of SUI was based on the discretion of the urogynecologist. Nonsurgical and surgical treatments for SUI were offered to eligible participants.
Study Design
This was a prospective pilot study approved by an intuitional review board and performed at a large academic center in the Northeast. Women with a new diagnosis of clinical stage I or II endometrial cancer who screened positive for SUI and planned surgical treatment for their endometrial cancer were eligible. Women were screened for SUI with a single question: “Do you ever leak urine when you cough, sneeze, jump, or laugh?” All participants were offered referral to a urogynecologist for evaluation of their SUI, and evaluation of SUI was based on the discretion of the urogynecologist. Nonsurgical and surgical treatments for SUI were offered to eligible participants.